Inflammatory manifestations in vasculitis: From immune complexes to other immunological forms;Ontstekingsverschijnselen bij vasculitis: Van immuuncomplexen tot pauci- immune vormen

Acta Clinica Belgica

Volumn 53, Issue 2, 1998, Pages 83-91

  Blockmans, D ^a   Bobbaers, H ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ALLERGIC VASCULITIS; ANAPHYLACTOID PURPURA; AORTA ARCH SYNDROME; ARTICLE; CHURG STRAUSS SYNDROME; CRYOGLOBULINEMIA; HISTOPATHOLOGY; IMMUNE COMPLEX DISEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PATHOPHYSIOLOGY; POLYARTERITIS NODOSA; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIGEN-ANTIBODY COMPLEX; ARTHRITIS, RHEUMATOID; CRYOGLOBULINEMIA; CYTOKINES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; T-LYMPHOCYTES; VASCULITIS;

EID: 0031799675     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Ohno S, Aoki K, Sugiura S et al. HLA-B5 and Beh-çet's disease. Lancet 1973; ii: 1383-4.
2. Calamia KT, Moore S B, Elveback LR. HLA DR locus antigens in polymyalgia rheumatica and giant cell arteritis. J Rheumatol. 1981; 8: 993-6.
3. Weyand CM, Goronzy JJ. Giant cell arteritis as an antigen-driven disease. Rheum Clin North Am. 1995; 21: 1027-32.
4. Hooks JJ, Jordan GU, Cupps T, Motsopoulos HM, Fauci AS, Notkin AL. Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. Arthritis Rheum. 1982; 25: 396-400.
5. Deguchi Y, Shihata N, Kishimoto S. Enhanced expression of the tumour necrosis factor/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis. Clin Exp Immunol. 1990; 81: 311-4.
6. Noranha IL, Kruger C, Andrassy K et al. In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int. 1993; 43:682-92.
7. Haskard D. Cytokines, growth factors, and interferons. In: LeRoy E (ed) Systemic Vasculitis. New York, Marcel Dekker, 1992, p 223.
8. Roche NE, Fulbright JW, Wagner AD et al. Correlation of interleukin 6 production and disease activity in polymyalgia rheumatica and giant cell arterfitis. Arthritis Rheum. 1993; 36: 1286-94.
9. Hunder GG, Sheps SG, Allen GL et al. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis : Comparison in a prospective study. Ann Intern Med. 1975; 82: 613-18.
10. Weyand CM, Tetzlaff N, Björnsson J et al. Disease patterns and tissue cytokine profiles in giant cell arterfitis. Arthritis Rheum. 1997:40: 19-26.
11. Cronstein B, Weissman G. The adhesion molecules of inflammation. Arthritis Rheum. 1993; 36: 147-57.
12. Smith C. Cellular adhesion and interactions. In: Rich R (ed): Clinical Immunology: Principles and Practice. St. Louis, Mosby, 1995, p 76
13. Kansas GS, Ley K, Munro M et al. Regulation of leukocyte rolling and adhesion to high endothelial venules through the cytoplasmic domain of L-selectin. J Exp Med. 1993; 177: 833-8.
14. Gutfleisch J, Baumert E, Wolff-Vorbeck G et al. Increased expression of CD25 and adhesion molecules on peripheral blood lymphocytes of patients with Wegener's granulomatosis (WG) and ANCA positive vasculitides. Adv Exp Med Biol. 1993, 336: 397-409.
15. Takeuchi T, Amano K Sekine H et al. Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis. J Clin Invest. 1993; 92: 3008-16.
16. Carson CW, Beall LD, Hunder GG et al. Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus. J Rheumatol. 1993; 20:809-14.
17. Furakawa S, Imai K, Matsubara T et al. Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum. 1992; 35: 672-7.
18. Mannik M. Serum sickness and pathophysiology of immune complexes. In : Rich R (ed): Clinical Immunology : Principles and Practice. St.Louis, Mosby, 1995, p 1062
19. Gocke DJ, Hsu K, Morgan C et al. Association between polyarteritis and australia antigen. Lancet 1970; ii: 1149-53.
20. Ziff M. Viruses and the connective tissue diseases. Ann Intern Med. 1971; 75: 951-8.
21. Trepo CG, Zucherman AJ, Bird RC, Prince AM. The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Path. 1974; 27: 863-8.
22. Marcellin P, Calmus Y, Takahashi H et al. Latent hepatitis B virus (HBV) infection in systemic necrotizing vasculitis. Clin Exp Rheumatol. 1991; 9: 23-8.
23. Misiani R, Bellavita P, Fenili D et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med. 1992; 117:573-7.
24. Sansonno D, Cornacchiulo V, Iacobelli AR et al. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 1995. 21: 305-12.
25. Misiani R, Bellavita P, Fenili D et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med. 1994; 330: 751-6.
26. Aydintug AO, Tokgoz G, D'Cruz D et al. Antiendothelial cell antibodies in patients with Behçet's disease. Clin Immunol Immunopathol. 1993; 67: 157-62.
27. Leung DY, Collins T, Lapierre LA et al. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest. 1986; 77: 1428-35.
28. Sima D, Thiele B, Turowski A et al. Anti-endothelial antibodies in Takayasu arteritis. Arthritis Rheum. 1994; 37: 441-3.
29. Del Papa N, Guidali L, Sironi M et al. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum. 1996; 39: 758-66.
30. Chan TM, Frampton G, Jayne DRW et al. Clinical significance of antiendothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasm antibodies. Am J Kidney Dis. 1993; 22: 387-92.
31. Göbel U, Eichhorn J, Kettritz R et al. Disease activity and autoantibodies to endothelial cells in patients with Wegener's granulomatosis. Am J Kidney Dis. 1996; 28: 186-94.
32. Damianovich M, Gilburd B, George J. Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model. J Immunol. 1996; 156: 4946-51.
33. van der Zee JM, Siegert CEH, De Vreede TA et al. Characterisation of anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol. 1991; 84: 238-44.
34. Del Papa N, Conforti G, Gambini D et al. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol. 1994; 70: 211-16.
35. D'Cruz DP, Houssiau FA, Ramirez G et al. Anti-endothelial cell antibodies in systemic lupus erythematosus: A potential marker for nephritis and vasculitis. Clin Exp Immunol. 1991; 85: 245-61.
36. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody : possible arbovirus aetiology? BMJ. 1982; 285: 606.
37. Van der Woude FJ, Rasmussen N, Lobatto S et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's Granulomatosis. Lancet 1985; i, 425-9.
38. Niles JL, McCluskey RT, Ahmad MF, Arnaout MA. Wegener's Granulomatosis autoantigen is a novel proteinase. Blood 1989; 74: 1888-93.
39. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988; 318: 1651-7.
40. Nolle B, Speckx U, Ludemann J et al. Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med. 1989; 111: 28-40.
41. Blockmans D, Stevens E, Mariën G, Bobbaers H. Clinical spectrum associated with positive ANCA-titers in 94 consecutive patients: is there a relation with PR 3 negative c-ANCA and hypergammaglobulinemia? Ann Rheum Dis, in press.
42. Raynauld JP, Bloch DA, Fries JF. Seasonal variation in the onset of Wegener's granulomatosis, polyarteritis nodosa and giant cell arteritis. J Rheumatol. 1993; 20: 1524-6.
43. Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA. The epidemiology of Wegener's granulomatosis. Arthritis Rheum. 1996; 39: 87-92.
44. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL. Activated neutrophils express proteinase 3 on their plasma membrane in vitro, and in vivo. Clin Exp Immunol. 1994; 95: 244-50.
45. Mayet WJ, Meyer zum Büchenfelde KH. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol. 1993, 94: 440-6.
46. Mayet WJ, Schwarting A, Orth T, Duchmann R, Meyer zum Büschenfelde KH. Antibodies to proteinase 3 mediate expression of vascular cell adhesion. Clin Exp Immunol. 1996; 103: 259-67.
47. Mayet WJ, Csernok E, Szymkowiak C, Gross WL, Meyer zum Büschenfelde KH. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 1993; 82: 1221-9.
48. Falk RJ, Terrell RS, Charles LA. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA. 1990; 87: 4115-9.
49. Reumaux D, Vossebeld PJM, Roos D, Verhoeven AJ. Effect of tumor necrosis factor-induced integrin activation on Fcγ receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 1995; 86: 3189-95.
50. Dolman KM, Stegeman CA, van de Wiel BA et al. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-α1-antitrypsin complexation to disease activity in Wegener's granulomatosis. Clin Exp Immunol. 1993; 93: 405-10.
51. Griffith ME, Lovegrove JU, Gaskin G, Whitehouse DB and Pusey CD. C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-anti-neutrophil cytoplasmic antibody positivity with the S allele. Nephrol Dial Transplant. 1996; 11:438-43.
52. Segelmark M, Elzouki AN, Wieslander J, Eriksson S. The PiZ gene of α1- antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int. 1995; 48: 844-50.
53. Davenport A, Lock RJ, Wallington T. Clinical Significance of the serial measurement of autoantibodies to neutrophil cytoplasm using a standard indirect immunofluorescence test. Am J Nephrol. 1995; 15: 201-7.
54. Blockmans D, Vandenbon C, Macken T, Stevens E, Bobbaers H. Wegener's granulomatosis: a study on 50 patients. Eur J Int Med. 1997; 8: 19-26.
55. Tomer Y, Gilburd B, Blank M et al. Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice: Pathogenetic role in experimental vasculitis. Arthritis Rheum. 1995; 38: 1375-81.
56. Schlesier M, Kaspar T, Gutfleisch J, Wolff-Vorbeck G, Peter HH. Activated CD4+ and CD8+ T-cell subsets in Wegener's granulomatosis. Rheumatol Int. 1995; 14: 213-9.
57. Heesen C, Kekow J, Rautmann A et al. Correlation of soluble interleukin 2 receptor levels with disease activity in Wegener's granulomatosis. Am J Kidney Dis. 1991; 18: 205.
58. Lai KN, Lockwood CM. Serum soluble interleukin 2 receptor levels in anti-neutrophil cytoplasmic autoantibodies -positive systemic vasculitis. Postgrad Med J. 1993; 69: 708-11.
59. Ballieux BEPB, Van der Burg SH, Hagen EC et al. Cell-mediated autoimmunity in patients with Wegener's granulomatosis. Clin Exp Immunol. 1995; 100: 186-93.
60. Weyand CM, Schonberger J, Oppitz U et al. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J Exp Med. 1994; 179: 951-60.
61. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med. 1994; 121: 484-91.
62. Seko Y, Minota S, Kawasaki A et al. Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu's arteritis. J Clin Invest. 1994; 93: 750-8.
63. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248: 705-11.
64. Abe H, Kotzin BL, Jujo K et al. Selective expansion of T cells expressing T-cell receptor variable regions V β 23 and V β 8 in Kawasaki disease. Proc Natl Acad Sd USA. 1992; 89: 4066-70.
65. Takeshita S, Kawase H, Yamamoto M et al. Increased expression of human 63-kD heat shock protein gene in Kawasaki disease determined by quantitative reverse transcription -polymerase chain reaction. Pediatr Res. 1994; 35: 179-83.
66. Simpson J, Skinner MA, Geursen A et al. Peripheral blood T lymphocytes in systemic vasculitis: increased T cell receptor Vβ2 gene usage in microscopic polyarteritis. Clin Exp Immunol. 1995; 101: 220-6.
67. Guilievin L, Lhote F, Léon A et al. Treatment of polyarteritis nodosa related to hepatitis B virus with short-term steroid therapy associated with antiviral agents and plasma exchange. A prospective trial in 33 patients. J RheumatoL 1993; 20: 289-98.
68. Stegeman CA, Cohen Tervaert JW, De Jong PE, Kallenberg CGM. Trimethoprim-sulfamethoxazole (cotrimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med. 1996; 335: 16-20.
69. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int. 1991; 40: 757-63.
70. Newsburger JW, Takahashi M, Burns JC et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986; 315: 341-7.
71. Rossi F, Jayne DRW, Lockwood CM, Kazatchkine MD. Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin Exp Immunol. 1991; 83: 298-303.
72. Jayne DRW, Esnault VLM, Lockwood CM. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin. J Autoimmunity. 1993; 6: 207-19.
73. Strunz MP, Csernok E, Gross WL. Incidence and disease associations of a proteinase 3-antineutrophil cytoplasmic antibody idotype (5/7 Id) whose antidio-type inhibits proteinase 3-antineutrophil cytoplasmic antibody antigen binding activity. Arthritis Rheum. 1997; 40: 135-42.
74. Hagen EC, de Keizer RJW, Andrassy K et al. Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin. Clin Nephrol. 1995; 43: 351-9.
75. Lockwood CM, Thiru S, Isaacs JD et al. Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet 1993; 341: 1620-4.
76. Mathieson PW, Cobbold SD, Hale G et al. Monoclonal antibody therapy in systemic vasculitis. N Engl J Med. 1990; 323: 250-4.